SCHEMBL14829348

SCHEMBL14829348

O=[N+]([O-])c1ccc(-c2ccc(CCO)nc2)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.53
MAPT P10636 4/20 0.53
LMNA P02545 2/20 0.53
ALDH1A1 P00352 2/20 0.53
KDM4E B2RXH2 1/20 0.53
GAA P10253 1/20 0.53
MEN1 O00255 1/20 0.43
CYP1A2 P05177 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2C19 P33261 1/20 0.43
KMT2A Q03164 1/20 0.43
DYRK1A Q13627 1/20 0.43
DYRK1B Q9Y463 1/20 0.43
PDGFRB P09619 1/20 0.41
PDGFRA P16234 1/20 0.41
POLB P06746 1/20 0.41
MAPK1 P28482 1/20 0.41
CA12 O43570 1/20 0.40
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14658480 0.87 TSHR (0.55) TSHRMAPTLMNAALDH1A1KDM4E
SCHEMBL14829580 0.84 MAPT (0.53) TSHRMAPTLMNAALDH1A1KDM4E
SCHEMBL27178747 0.81 MAPT (0.56) MAPTLMNAALDH1A1KDM4EGAA
SCHEMBL14829257 0.78 MAPT (0.53) MAPTLMNAALDH1A1KDM4EGAA
SCHEMBL14829668 0.75 HTR2A (0.41)
SCHEMBL28240321 0.74 MAPT (0.70) MAPTLMNAALDH1A1KDM4EGAA
SCHEMBL28241141 0.73 MAPT (0.62) MAPTLMNAALDH1A1KDM4EGAA
SCHEMBL1126175 0.73 ADRA2A (0.49) TSHRMAPTLMNAALDH1A1KDM4E
SCHEMBL27178714 0.73 TSHR (0.63) TSHRMAPTLMNAALDH1A1KDM4E
SCHEMBL12138422 0.72 MAPT (0.53) TSHRMAPTLMNAALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2760854-A1 IMIDAZOLE DERIVATIVES AS CYP17 INHIBITORS FOR THE TREATMENT OF CANCER Endo Pharmaceuticals Inc. (US) 2014-08-06 EP disclosed
WO-2013049565-A1 IMIDAZOLE DERIVATIVES AS CYP17 INHIBITORS FOR THE TREATMENT OF CANCER ENDO PHARMACEUTICALS INC. (US) 2013-04-04 WO disclosed